The acute effects of small doses of intravenous propranolol on renin release and on circulatory dynamics were studied at the time of renal arteriography in 12 persons with essential hypertension. All of the subjects had a normal peripheral renin response to chronic sodium depletion and all had normal renal function. Seven subjects received a 10-mEq sodium diet for at least 4 days prior to study and five received a 200-mEq sodium diet. At the time of arteriography, arterial blood pressure, pulse rate, cardiac output, renal blood flow, and arterial and renal venous renin activity were measured before and 6-20 minutes after the intravenous administration of propranolol (9-18 jtg/kg). Average renin secretion rate in the salt-depleted subjects fell from 367 ± 80 (SEM) U/ml per 100 g/min to 122 ± 51 U/ml per 100 g/min (/> _ 0.03), and renal plasma flow fell from 189 to 155 ml/min per 100 g (P -0.018). We also found that in the salt-loaded subjects, renal plasma flow fell from 213 to 184 ml/min per 100 g (P -0.025), whereas renin secretion did not change significantly. Furthermore we found that mean arterial pressure and cardiac index did not change significantly in either group. We conclude that propranolol rapidly blocks renin release despite circulatory changes which ordinarily constitute a stimulus for renin secretion, i.e., renal vasoconstriction and reduced renal blood flow.
PROPRANOLOL exerts several pharmacological effects including production of/3-adrenergic receptor blockade and local anesthesia and a quinidine-like action of cell membranes. This agent now is used widely in the management of patients with cardiac arrhythmias or angina pectoris, and is being used increasingly to treat patients with hypertension. The mechanism responsible for the hypotensive effect of propranolol is not clear. Possible explanations include: reduction of cardiac output, 1 central nervous system effect, 2 and decreased renin release. 1 It has been suggested that propranolol is most effective in renin-dependent forms of hypertension. 4 Although oral administration of propranolol has been shown to reduce peripheral plasma renin activity (PRA) in human subjects after a variety of challenges, 8 the relationship of reduced renin release to propranolol-induced hemodynamic changes has not been investigated in man and is the subject of this report.
Methods
Twelve subjects with essential hypertension participated in the study. In all, diastolic blood pressure was elevated to levels above 110 mm Hg on at least two separate outpatient visits prior to admission. Eight of the 12 had not received prior antihypertensive therapy, two had received therapy with thiazide diuretic agents, one had been treated with hydrochlorothiazide, methyldopa, and hydralazine, and one with spironolactone, methyldopa, and guanethidine. All medications were discontinued at least 2 weeks prior to study. The study protocol was approved by the Human Experimentation Committee of the Peter Bent Brigham Hospital. All of the subjects were informed of the experimental nature of the protocol and gave their written consent.
The subjects (seven female and five male) ranged in age from 19 to 42 years; nine were white. All were judged to be free of complicating illness after undergoing a clinical evaluation consisting of a complete history and physical examination; routine urinalysis; urine culture; hematocrit; white blood cell and differential counts; measurement of serum creatinine, glucose, sodium potassium, chloride, bicarbonate, calcium, phosphorus, uric acid, cholesterol, and triglycerides; serum protein by electrophoresis; antinuclear antibodies; 24-hour endogenous creatinine clearance; urinary excretion of vanillylmandelic acid (VMA); total metanephrines, 17-hydroxysteroids, 17-ketosteroids; and rapid sequence intravenous pyelograms. The subjects were admitted to a metabolic ward and given a constant diet containing a daily intake of 2,500 calories, 2,500 ml of fluid, 100 mEq of potassium, and either 10 or 200 mEq of sodium for at least 4 days before study. Twenty-four-hour sodium excretion was measured daily to access metabolic balance. Peripheral PRA was measured after 3 hours of ambulation when each subject had reached metabolic balance on a 10-mEq sodium diet, and all 12 subjects were found to have peripheral PRA levels within our laboratory's range of normal relative to the sodium intake. Seven of the subjects underwent hemodynamic study while receiving a 10-mEq sodium diet and 5 were studied while receiving a 200-mEq sodium diet. All subjects were found to be in metabolic balance at the time of hemodynamic study.
The subjects were studied after an overnight fast. Diazepam (5-10 mg, im) was given 1 hour before the study. Percutaneous selective renal arterial and venous catheterization was performed under local anesthesia with fluoroscopic monitoring. The arterial catheter was used to monitor blood pressure and heart rate, to inject xenon, and for arterial blood sampling. A venous catheter was used to draw blood from the renal veins and for the injection of indocyanine green.
Blood pressure was measured with a Statham P23Dc pressure transducer and recorded on an Electronics for Medicine recorder simultaneously with the electrocardiogram and instantaneous pulse rate. Mean blood pressure was calculated as the sum of diastolic pressure and Vi s of the pulse pressure. Cardiac output was measured by the indicator-dilution technique using indocyanine green dye, with injection into the inferior vena cava at the level of the diaphragm and sampling from the abdominal aorta. Renal and systemic vascular resistances were calculated from the Frank formula: Resistance (dyne cm" 1 sec) = mean pressure (mm Hg) x 1,330/cardiac output (ml/sec). Renal blood flow (ml/sec per 100 g) was used to estimate renal vascular resistance. Mean renal blood flow was measured from the initial slope of 133 Xe disappearance with external probe counting determined graphically with a hematocritcorrected partition coefficient.* Curves reanalyzed on a coded basis showed a coefficient of variation of 7%.
The subjects were studied no sooner than 30 minutes after renal arteriography at a time when they were comfortable and blood pressure and pulse rate were stable. At this time arterial and renal venous blood samples were obtained for the measurement of PRA. Cardiac output, blood pressure, and heart rate were recorded and renal blood flow was measured. The subjects then received propranolol, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] g/kg, iv, over I minute. Ten minutes later (range, 5-20 minutes) measurements were repeated.
PRA was measured by a modification of the method of Boucher et al. 7 and Blaufox et al.' Renin secretory rates were calculated as the product of renal plasma flow and venoarterial renin difference.
Statistical probability was evaluated with the paired data /-test or by standard regression formulas.*
Results

PLASMA RENIN ACTIVITY
Renal vein renin activity fell significantly from 781 ± 9 8 (SEM) ng/100 ml per 3 hours to 626 ± 78 ng/100 ml per 3 hours (20%) promptly after propranolol was administered intravenously to subjects receiving a 10-mEq sodium diet (P < 0.005). Arterial PRA did not fall significantly (595 ± 113 vs 513 ± 90 ng/100 ml per 3 hours). Resting PRA was 50% lower in subjects receiving a 200-mEq sodium diet and did not change significantly in either arterial or renal venous blood when propranolol was administered ( Fig. 1 ).
Nine measurements of renin secretion rates before and after propranolol were made in five subjects on a 10-mEq sodium diet (Table 1 ). Blood samples were drawn from the aorta and from the right and left renal veins before and after propranolol in four of the subjects. Renin secretion fell significantly to 37% of control values (P < 0.03). That the magnitude of the reduction (x) related closely to the control renin secretion rate (y), is apparent from Figure 2 (y = -0.99x + 123; r = -0.86; f = +19.6; P < 0.01). Thus it appears the greater the stimulus that sodium restriction provided, the larger was the reduction induced by pro- pranolol. Four unilateral measurements were made in four subjects on a 200-mEq sodium diet and did not show a consistent change in renin secretion after propranolol; in two subjects, values did not change, in one they decreased, and in one they increased. The last subject became very anxious during the study.
RENAL PLASMA FLOW
Renal plasma flow fell significantly after propranolol was given to subjects on a diet containing either 10 mEq (P < Table 2 ).
HEMODYNAMIC MEASUREMENTS
At the time of renal arteriography, resting arterial blood pressure was significantly higher in the group of subjects receiving 10 mEq of sodium in the diet (P < 0.05) ( Table 2) . Heart rate decreased significantly in the group of subjects receiving a 200-mEq sodium diet but the decrease was not significant in the group receiving 10 mEq of sodium. Peripheral vascular resistance rose significantly after propranolol was administered to subjects receiving the "high" salt diet but the increase was not significant in patients receiving the "low" salt diet.
Discussion
The control of renin release is complicated and involves the interplay of a number of factors as the body adjusts to TABLE 2 Hemodynamic Effects of Propranolol changing physiological circumstances. The major factors involved are the vascular receptor in the renal afferent arteriole, the macula densa, the sympathetic nervous system, and a number of blood-borne substances. 10 The vascular receptor includes the juxtaglomerular cells and portions of the afferent glomerular arteriole. The receptor responds to changes in wall tension caused by changes in perfusion pressure, 11 sympathetic nerve activity, 11 and intrinsic changes in vascular smooth muscle during renal autoregulation." The macula densa responds to changes in the rate of sodium delivery, 14 but the relative importance of this mechanism in the control of renin release is not clear. A number of humoral agents are known to effect renin release, including sodium, 16 -" potassium, 17 angiotensin I I , " catecholamines," estrogens, 10 adrenal steroids, 11 and antidiuretic hormone (ADH). 22 Although the renal sympathetic nerves are an important modulatory factor in the control of renin release, they are not essential, as increased renin secretion in response to sodium depletion has been demonstrated in dogs with bilateral renal denervation." In experimental animals it has been shown that /3-adrenergic receptor blockade prevents the increase in renin secretion produced by hypoglycemia, 14 brainstem stimulation, 25 infusion of sympathomimetic amines, 1 ' acute hemorrhage, adrenalectomy, chronic salt depletion, and acute renal artery constriction. 27 Although evidence has been presented to show that renin secretion is also prevented by a-adrenergic receptor blockade, 2 " other laboratories have observed that agents which block aadrenergic receptors actually potentiate stimulated renin release. 1 
"' "
In earlier studies, Nies and his co-workers' 0 concluded that the changes in canine renal hemodynamics observed after the administration of propranolol were secondary to a decrease in cardiac output.
In the present study we have found that doses of propranolol which are too small to cause a significant peripheral hemodynamic change result in an elevated renal vascular resistance and diminished renal blood flow in both salt-depleted and salt-loaded human subjects. This observation in man is consistent with the results of earlier studies in the dog in which Carriere" found that infusion of small doses of propranolol directly into the renal artery resulted in a significant reduction of renal blood flow without systemic hemodynamic changes. As this effect could be blocked by phenoxybenzamine, Carriere suggested that propranolol had a direct effect on intrarenal a-adrenergic receptors. Despite the fall in renal blood flow, which ordinarily constitutes a potent stimulus for renin secretion, 11 we found that propranolol significantly decreased both renal vein renin activity and renin secretion rates in salt-depleted human subjects. A consistent effect on renin release was not seen in the small number of measurements made in saltloaded subjects whose renin secretion rates were relatively low before the administration of propranolol; this may have made detection of further small changes beyond the sensitivity of our methods. As an effect of propranolol on renin secretion was seen in salt-depleted subjects, this study supports the concept that renin release in response to sodium depletion is modulated by /3-adrenergic receptors. The observation that renal vein renin activity after /3-adrenergic blockade in salt-depleted subjects was higher than levels in subjects on a high salt diet without /?-adrenergic blockade suggests that the increase in renin activity after salt depletion does not depend entirely upon the sympathetic nervous system.
Since it has been demonstrated that the optical isomer of propranolol which has a local anesthetic effect without /3-receptor blocking activity does not reduce renin secretion in the isolated perfused rat kidney," it is reasonable to conclude that the results of the present study, in which extremely low doses of propranolol were used, were due to a /9-blocking effect. Although the addition of excess propranolol to in vitro systems of renin assay has not been found to have an effect on measured renin activity, 4 -"• " the possibility that propranolol reduces measured renal vein renin activity by stimulating the release of a renin inhibitor, or by preventing the release of an activator, has not been assessed. Similarly, the effect of prior diazepam administration on the observations reported herein has not been examined.
In studies on humans propranolol has been found to block the rise in PRA caused by upright posture or diuretics, 3 -5 to lower blood pressure in proportion to its effect on PRA in persons with various forms of hypertension, 4 to lower PRA without an effect on blood pressure in persons with renovascular hypertension,' and to lower blood pressure without significantly affecting PRA in patients with essential hypertension receiving long-term diuretic therapy." As a result of studies showing increased PRA following salt depletion in patients on long-term propranolol therapy, Bravo et al. 14 have postulated that propranolol blocks renin release without effecting renin synthesis. All of these studies in man have depended on the measurement of an equilibrium peripheral PRA. Although the present study showed that propranolol caused significant changes in renin secretion rates, renal vascular resistance, and renal blood flow at a time when measurement of peripheral arterial renin activity and systemic arterial blood pressure did not show significant changes, it should be emphasized that our observations were made over a relatively short period and might not account for the results of earlier clinical studies performed over prolonged periods of time. VOL. 39, No. 4, OCTOBER 1976 Koiw New York, Springer-Vcrlag, 1972, pp 37-44 29. Ganong WF Effect of sympathetic activity and ACTH on rcnin and aldosterone secretion. THE PULMONARY CIRCULATION of the fetus has been shown to be more responsive to hypoxemia and to vasoactive agents than is that of the adult. 1 '' However, previous observations on these responses were made on fetal lambs exteriorized from the uterus, usually with the ewe under general anesthesia. Since these procedures alter the distribution of blood flow in the fetus 7 and may modify responses of the pulmonary circulation, pulmonary vascular responses of the undisturbed fetus in utero could not be defined. Furthermore, in previous studies little attempt was made to delineate the effects of graded hypoxemia, nor was there a detailed consideration of possible gestational differences in pulmonary vascular responses.
We designed a preparation to study changes in pulmonary blood flow and pulmonary vascular responses of fetal lambs in utero. After recovery from surgery, pulmonary blood flow was monitored continuously with an electromagnetic flow transducer, and pulmonary arterial pressures were mea-sured. Constriction of the pulmonary vascular bed by graded hypoxemia and dilation of the pulmonary vascular bed by the infusion of acetylcholine (ACh) were studied during advancing gestation. The role of the sympathetic nervous system in the hypoxemic response was assessed.
Methods
Twenty-six time-dated pregnant sheep with gestational periods ranging from 0.66 to 0.93 (100-140 days) were studied. Low spinal analgesia was produced with 2-3 ml of 1% tetracaine hydrochloride. The abdomen was opened in the midline, a small incision was made in the uterine wall to expose a fetal hindlimb, and polyvinyl catheters were inserted into a hindlimb artery and vein.'-" Through a separate incision catheters were inserted into the fetal carotid artery and jugular vein and, through a purse-string suture, the trachea. A thoracotomy then was performed in the 3rd or 4th left intercostal space, the pericardium was opened, and the main pulmonary trunk was isolated.
In the fetal lamb the right ventricle ejects into the pulmonary trunk, which continues into the ductus arteriosus. The blood vessels to the lung arise as a common main pulmonary artery segment which divides into the left and right branch pulmonary arteries (Fig. 1) . The main pulmonary artery is of variable length; in nine fetuses a precalibrated electromagnetic flow transducer was placed around it
